153 related articles for article (PubMed ID: 14684698)
1. Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism.
Narita I; Goto S; Saito N; Song J; Omori K; Kondo D; Sakatsume M; Gejyo F
J Med Genet; 2003 Dec; 40(12):e130. PubMed ID: 14684698
[No Abstract] [Full Text] [Related]
2. [Gene polymorphisms of renin-angiotensin system in patients with kidney diseases].
Narita I; Gejyo F
Nihon Rinsho; 2004 Oct; 62(10):1811-5. PubMed ID: 15500123
[TBL] [Abstract][Full Text] [Related]
3. Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy.
Narita I; Goto S; Saito N; Song J; Omori K; Kondo D; Sakatsume M; Gejyo F
Kidney Int; 2003 Sep; 64(3):1050-8. PubMed ID: 12911556
[TBL] [Abstract][Full Text] [Related]
4. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.
Dillon JJ
Semin Nephrol; 2004 May; 24(3):218-24. PubMed ID: 15156527
[TBL] [Abstract][Full Text] [Related]
6. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
Yoshida H; Mitarai T; Kawamura T; Kitajima T; Miyazaki Y; Nagasawa R; Kawaguchi Y; Kubo H; Ichikawa I; Sakai O
J Clin Invest; 1995 Nov; 96(5):2162-9. PubMed ID: 7593601
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis.
Woo KT; Lau YK; Chan CM; Wong KS
Ann Acad Med Singap; 2008 May; 37(5):372-6. PubMed ID: 18536822
[TBL] [Abstract][Full Text] [Related]
8. The renin--angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy.
Ong-Ajyooth S; Ong-Ajyooth L; Limmongkon A; Tiensingh A; Parichatikanon P; Nilwarangkur S
J Med Assoc Thai; 1999 Jul; 82(7):681-9. PubMed ID: 10511770
[TBL] [Abstract][Full Text] [Related]
9. ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients.
Han SY; Kwon YJ; Jo SK; Shin JH; Cha DR; Cho WY; Pyo HJ; Kim HK
Korean J Intern Med; 2000 Jan; 15(1):13-8. PubMed ID: 10714086
[TBL] [Abstract][Full Text] [Related]
10. Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin-angiotensin system inhibitors on its prognosis.
Sugiura N; Moriyama T; Miyabe Y; Karasawa K; Nitta K
J Pathol Clin Res; 2021 Nov; 7(6):616-623. PubMed ID: 34185389
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme gene polymorphisms in renal disease: clinically relevant?
Taal MW
Curr Opin Nephrol Hypertens; 2000 Nov; 9(6):651-7. PubMed ID: 11128428
[TBL] [Abstract][Full Text] [Related]
12. Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients.
Narita I; Goto S; Saito N; Song J; Ajiro J; Sato F; Saga D; Kondo D; Akazawa K; Sakatsume M; Gejyo F
Hypertension; 2003 Sep; 42(3):304-9. PubMed ID: 12885793
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy.
Yorioka T; Suehiro T; Yasuoka N; Hashimoto K; Kawada M
Clin Nephrol; 1995 Aug; 44(2):80-5. PubMed ID: 8529313
[TBL] [Abstract][Full Text] [Related]
14. ACE genotype and progression of IgA nephropathy.
Fukushima T; Nomura S; Kawai S; Osawa G
Lancet; 1995 Aug; 346(8974):571. PubMed ID: 7658790
[No Abstract] [Full Text] [Related]
15. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy.
Zhu X; Kong D; Zhang L; Sun Y; Na S; Han C; Jin X
Hum Pathol; 2013 Dec; 44(12):2806-13. PubMed ID: 24157068
[TBL] [Abstract][Full Text] [Related]
16. Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study.
Park S; Baek CH; Go H; Kim YH; Min SI; Ha J; Kim YC; Lee JP; Kim YS; Moon KC; Park SK; Lee H
BMC Nephrol; 2019 Sep; 20(1):354. PubMed ID: 31510954
[TBL] [Abstract][Full Text] [Related]
17. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis.
Woo KT; Lau YK; Zhao Y; Liu FE; Tan HB; Tan EK; Stephanie FC; Chan CM; Wong KS
Cell Mol Immunol; 2007 Jun; 4(3):227-32. PubMed ID: 17601378
[TBL] [Abstract][Full Text] [Related]
18. [Some metabolic and genetic risk factors and the progression of IgA nephropathy--preliminary report].
Sulikowska B; Czarny J; Rość D; Odrowaz-Sypniewska G; Manitius J; Sliwka DM
Pol Merkur Lekarski; 2006 Aug; 21(122):132-5; discussion 136. PubMed ID: 17144095
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore.
Lau YK; Woo KT; Choong HL; Zhao Y; Tan HB; Chong SM; Tan EK; Yap HK; Wong KS
Nephron Physiol; 2004; 97(1):p1-8. PubMed ID: 15153745
[TBL] [Abstract][Full Text] [Related]
20. ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy.
Teranishi J; Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Okada N; Moriyama T; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):633-41. PubMed ID: 24452035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
